Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has shared an announcement.
Sai Life Sciences Ltd. has announced a significant capacity addition by acquiring a 1.21-acre land parcel in Shamirpet, Hyderabad, with an investment of approximately Rs. 15 crore from internal accruals. This investment will be used to establish an R&D facility that will enhance the existing Unit II Hyderabad Facility, with partial operations expected to commence by Q4 of the fiscal year ending March 2026, which is likely to bolster the company’s R&D capabilities and market position.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. operates in the pharmaceutical sector, focusing on drug discovery, development, and manufacturing services. The company is dedicated to augmenting its R&D capabilities and strengthening its presence in the pharmaceutical market.
YTD Price Performance: -11.07%
Average Trading Volume: 339,609
For an in-depth examination of SAILIFE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue